ANGPT2 and type 2 diabetes mellitus: In patients with T2DM, elevated plasma levels of TGF- β1, CXCL-16 and angiopoietin-2 have been shown as independent predictors of albuminuria and these molecular markers can improve renal risk models beyond established clinical risk factors (Scurt et al., 2019).